Chronic Lymphoid Leukemia in Relapse
3 clinical trials · Condition
◉ Watch Chronic Lymphoid Leukemia in Relapse
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL (NCT05360238) | Mustang Bio | 2022-05-24 |
| Belimumab in Patients with Chronic Lymphocytic Leukemia (NCT05069051) | University Hospital Tuebingen | 2022-01-19 |
| Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (NCT04030195) | Precision BioSciences, Inc. | 2020-03-24 |
Track Chronic Lymphoid Leukemia in Relapse automatically
Every clearance here is in the API, with alerts when new ones post.